Director Fails to Disclose FDA Orders Halting Two Drugs
It is axiomatic firms must disclose of material information that is complete and accurate. Thus, for example, when the president of a regulated entity speaks to investors regarding communications with the firm’s regulator, it is critical that the information about …
Director Fails to Disclose FDA Orders Halting Two Drugs
Read More »
This Week In Securities Litigation (Week of December 2, 2024)
Last week as many celebrated Thanksgiving the Commission filed three new enforcement actions. One focused on Rule 105 compliance, a second on muni registration and a third on an offering fraud. Be careful, be safe this week SEC Enforcement – …
This Week In Securities Litigation (Week of December 2, 2024)
Read More »